Shares of Phreesia, Inc. (NYSE:PHR – Get Free Report) have been assigned an average rating of “Hold” from the nineteen brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $14.00.
A number of research analysts recently weighed in on PHR shares. Canaccord Genuity Group reissued a “buy” rating and issued a $16.00 price objective on shares of Phreesia in a research note on Thursday, September 3rd. Weiss Ratings raised Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, October 19th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a report on Tuesday, October 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a $19.00 price target on shares of Phreesia in a report on Thursday, September 3rd. Finally, DA Davidson lifted their price target on shares of Phreesia from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday.
Insider Transactions at Phreesia
Institutional Trading of Phreesia
Several hedge funds have recently added to or reduced their stakes in PHR. Pale Fire Capital SE bought a new position in Phreesia in the 1st quarter worth approximately $72,481,000. BlackRock Inc. bought a new position in shares of Phreesia during the 2nd quarter worth about $72,234,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Phreesia during the 2nd quarter worth about $6,274,000. Bank of America Corp DE acquired a new position in shares of Phreesia during the second quarter valued at about $6,066,000. Finally, Ieq Capital LLC acquired a new position in shares of Phreesia during the second quarter valued at about $3,689,000. Institutional investors own 92.10% of the company’s stock.
Phreesia Stock Down 3.9%
PHR stock opened at $11.41 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.33. Phreesia has a 1 year low of $7.77 and a 1 year high of $21.24. The company has a fifty day simple moving average of $11.42 and a 200 day simple moving average of $10.79. The firm has a market cap of $708.22 million, a PE ratio of 67.12 and a beta of 0.75.
Phreesia (NYSE:PHR – Get Free Report) last issued its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%. The business had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. During the same quarter in the prior year, the company posted $0.01 earnings per share. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Sell-side analysts anticipate that Phreesia will post 0.33 EPS for the current fiscal year.
Phreesia Company Profile
Phreesia, Inc. provides software and services that help healthcare organizations manage interactions with patients. Its platform supports tasks such as patient registration and intake, appointment scheduling, payments, and communications before and after visits. Phreesia’s tools include digital and mobile options for completing forms and sharing information, as well as services designed to help providers engage patients and streamline administrative workflows. The company serves healthcare providers and organizations primarily in the United States.
Recommended Stories
- Five stocks we like better than Phreesia
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
